Japan Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Learning HTML & CSS shouldn't be difficult. Master Trainer, Mark Lassoff, will teach you everything you need to know to create a creative and professional web site in 4 hours. From our sponsors

Japan Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: High overall and per-capita pharmaceutical expenditures, an ageing population, strong patent respect and a generally stable economic and political environment make Japan highly attractive to pharmaceutical investors. However, a downside risk to this trend is its shrinking population, limiting growth potential not just in the pharmaceutical sector, but the economy overall. Headline Expenditure Projections ? Pharmaceuticals: JPY10,338.7bn (US$129.5bn) in 2012 to JPY10,992.8bn (US$112.2bn) in 2013; +6.3% in local currency terms and -13.4% in US dollar terms. Forecast slightly upgraded from Q413 due to a small increase in GDP growth projected by BMI’s Country Risk team, growth in US … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131618. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/japan-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions